| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
43,175 |
40,327 |
$3.60M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,885 |
10,281 |
$626K |
| 99205 |
Prolong outpt/office vis |
1,431 |
1,431 |
$237K |
| 99215 |
Prolong outpt/office vis |
2,155 |
2,115 |
$230K |
| 20611 |
|
2,453 |
1,813 |
$187K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,062 |
7,658 |
$129K |
| 99152 |
|
2,160 |
1,970 |
$99K |
| 62323 |
|
403 |
398 |
$89K |
| 64493 |
|
445 |
396 |
$76K |
| 72275 |
|
683 |
668 |
$71K |
| 64635 |
|
142 |
124 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
530 |
530 |
$61K |
| 64636 |
|
139 |
122 |
$50K |
| 76942 |
|
956 |
905 |
$46K |
| J7320 |
Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
260 |
131 |
$32K |
| 64494 |
|
425 |
378 |
$30K |
| L0648 |
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
40 |
40 |
$29K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,432 |
7,070 |
$27K |
| L0650 |
Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf |
24 |
24 |
$23K |
| 64495 |
|
321 |
280 |
$21K |
| 62370 |
|
117 |
110 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,845 |
3,478 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
773 |
745 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
900 |
867 |
$6K |
| 20553 |
|
85 |
81 |
$5K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
121 |
116 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,638 |
1,549 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32 |
32 |
$3K |
| 62321 |
|
13 |
13 |
$3K |
| 80305 |
|
387 |
355 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,005 |
880 |
$1K |
| 81005 |
|
533 |
489 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
19 |
17 |
$816.41 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
113 |
110 |
$388.65 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
38 |
38 |
$339.61 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
123 |
123 |
$26.58 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
448 |
422 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
108 |
103 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
339 |
327 |
$0.00 |
| G8432 |
Depression screening not documented, reason not given |
28 |
28 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
15 |
15 |
$0.00 |
| 1036F |
|
73 |
70 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
62 |
59 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
369 |
348 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
444 |
415 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
136 |
131 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
328 |
312 |
$0.00 |